WHO and ILO join forces to release new guidance on social protection for people affected by TB

The guidance includes approaches to expanding the coverage, quality and impact of existing social protection programs to people affected by TB.

Read More →

WHO launches updated guidance on HIV-associated TB

WHO releases consolidated guidelines on HIV-associated TB providing a single comprehensive source for the latest evidence-informed TB/HIV recommendations.

Read More →

An Activist’s Guide to Rifapentine TB Preventive Treatment: 3HP and 1HP

The new 2024 update of An Activist’s Guide to Rifapentine TB Preventive Treatment: 3HP and 1HP lays out what TB community advocates need to know about rifapentine-based TB preventive treatment.

Read More →

MSF publishes cost of its TB clinical trial

Transparency on clinical trial costs must become the norm to improve access to medical products worldwide.

Read More →

Community statement: Introduction of child-friendly formulation of rifapentine for short-course TB preventive treatment

Safeguarding children against TB takes center stage with introduction of child-friendly formulation of rifapentine for short-course TB preventive treatment.

Read More →

New Global TB Dictionary aims to standardize terminology in TB research

The dictionary aims to unify TB-related terminology and promote clearer communication by providing a common language for researchers, policy-makers, donors and affected communities.

Read More →

WHO: World TB Day newsletter

On World TB Day, WHO is calling for action on several fronts to ensure that the commitments made to end TB are achieved. A special newsletter edition compiles all WHO advocacy activities and key resources released in the lead-up to World TB Day.

Read More →

Mid-campaign report highlights what’s needed to win better, shorter TB treatments for all by end of 2024

With less than a year to go until the 1/4/6x24 Campaign deadline, the Getting Better Faster: Delivering on the Promise of New TB Treatments report outlines both progress made and remaining gaps toward achieving 1/4/6x24.

Read More →

Three wins needed to deliver new TB vaccines this decade

The TB Vax ARM outlines three key advocacy wins for the field to achieve by 2026 in order to effectively advance TB vaccine development. Check them out and sign a petition to show your support!

Read More →

Time for $5 Coalition launches global petition targeting medical test maker Cepheid and parent corporation Danaher

TB advocates protest outside the headquarters of Danaher in Washington, DC, demanding price drop to $5 per test.

Read More →

Page 1 of 131 · Total posts: 10

1 2 Last→